National Law Journal Recognizes Wilkinson Walsh’s Industry-Leading Products Liability/Mass Tort Trial Practice

WASHINGTON – The National Law Journal selected Wilkinson Walsh as one of its Washington D.C. Litigation Departments of the Year in Products Liability/Mass Torts. NLJ’s selection was based on Wilkinson Walsh’s string of trial victories in high-profile products liability cases.  Most recently, the firm, led by Alex Walsh, Kieran Gostin, and James Rosenthal, won a decisive victory in Bayer v. Farar, a certified consumer class action trial involving $600 million in claimed damages. Previously, the firm reeled off five straight victories in the Xarelto products liability litigation, with Beth Wilkinson, Alex Walsh, Brian Stekloff, Jeremy Barber, Tamarra Matthews Johnson, and Rakesh Kilaru serving in lead roles. NLJ’s profile on the firm highlights commentary from Beth, Alex, and Brian on their strategy and approach to litigation. “We believe that at the heart of every case is a simple compelling narrative, a narrative that shows the jury why our side should prevail,” …

ICYMI: Wilkinson Walsh Partners Alexandra Walsh and Rakesh Kilaru share their SCOTUS clerk stories

Super Lawyers highlights stories from court’s last 70 years WASHINGTON — Founding Partner Alexandra Walsh and Partner Rakesh Kilaru were two of the seven D.C. lawyers who shared their experiences working as SCOTUS clerks with Super Lawyers Magazine. Founding Partner Alexandra Walsh spoke with Super Lawyers about the moment she was called in for an interview to work for Associate Justice of the Supreme Court Stephen Breyer from 2003-04. Alexandra recalled the moment to Super Lawyers stating, “I had less than 12 hours to prepare. Breyer called me late afternoon and I went in the next morning. In some ways, that was liberating. I said, “Well, we’ll just see how it goes.” It felt a little bit like winning the lottery.” Partner Rakesh Kilaru described his time working in the office of Associate Justice of the Supreme Court Elena Kagan from 2011-12. Rakesh tells Super Lawyers, “We’d often have some pretty fun debates, where Kagan would ask …

Wilkinson Walsh Continues Its Ascent in Chambers and Partners

Firm and Attorneys Moved Up the Ranks in 2020 WASHINGTON — Continuing its rapid rise, Wilkinson Walsh made a strong showing in the 2020 Chambers and Partners rankings.  Chambers recognized the firm as a litigation and products liability powerhouse, and also spotlighted three of the firm’s founding partners. In recognition of the firm’s track record of success in bet-the-company cases, Chambers moved Wilkinson Walsh up to Band 2 for General Litigation.  Additionally, for the first time, Wilkinson Walsh received recognition for success in Product Liability & Mass Torts. Chambers and Partners described Wilkinson Walsh as an “impressive litigation boutique, noted for its expert handling of complex, bet-the-company cases for leading corporate clients across a wide range of sectors, with a substantial market share in the pharmaceutical industry.” Chambers also praised Wilkinson Walsh’s “enviable bench,” including “several leading practitioners with significant federal prosecutorial and public defense experience,” as well as the …

Wilkinson Walsh Celebrates Another Outstanding Year of High Stakes Trials and Accolades for the Next Generation of Trial Lawyers

WASHINGTON –Wilkinson Walsh enters its fifth year having cemented its status as the premier trial litigation boutique in the country. 2019 featured three high-stakes, high-pressure trials, in which different partners served as lead trial counsel and eight partners in total had stand-up roles. The firm continued to receive accolades for its successes in delivering results to its clients while deepening its diverse bench of go-to litigators.

Alexandra Walsh Named Law 360 Trials MVP of the Year

WASHINGTON – Wilkinson Walsh Founding Partner Alexandra Walsh was named one of Law360’s 2019 Trial MVPs of the Year. The award recognizes Walsh for leading “trial teams to a string of crucial victories for Bayer AG this year, persuading juries to reject a certified class action attacking the company’s One A Day vitamins as well as suits over its blood thinner Xarelto.”

American Healthcare Leader: “Wilkinson Walsh Help Bayer Stand Its Ground”

WASHINGTON — After the Wilkinson Walsh team won a decisive trial victory for Bayer in a $600 million certified consumer class action lawsuit brought on behalf of One A Day multivitamin consumers, American Healthcare Leader’s (AHL) Sara Deeter highlighted how Walsh and Eskovitz’s “confidence and strategy” helped Bayer win a “resounding victory” in such a “high stakes” case. Without calling any witnesses in the defense case, the Wilkinson Walsh team — led by Sean Eskovitz, Alex Walsh, James Rosenthal, and Kieran Gostin — relied on devastating cross-examinations of plaintiffs’ expert and fact witnesses, which were “pivotal” and “yielded further important insights.” The cross-examinations were so effective that it only took the jury one hour to reject plaintiffs’ claims that Bayer had misrepresented the health benefits of One A Day multivitamins.  The feature acknowledged one of Wilkinson Walsh’s key strategies to engaging with the jury in a case that centered on …

Wilkinson Walsh’s Beth Wilkinson, Alex Walsh Again Named “Top Women in Litigation” by Benchmark

WASHINGTON – For the second consecutive year, Wilkinson Walsh founding partners Beth Wilkinson and Alexandra Walsh were ranked among Benchmark Litigation’s “Top 250 Women in Litigation,” a recognition of “the most distinguished women in the world of litigation.” In addition, Beth Wilkinson was again named among the “Top 10 Female Litigators” in the country, which recognizes “a separate but elite group of leading lawyers who have been nominated specifically for their litigious acumen.” “Beth and Alex’s repeated recognition by Benchmark is a testament to their leadership at our firm and their expertise in the courtroom,” said Wilkinson Walsh Managing Partner Brant Bishop. “In an industry that continues to suffer from an underrepresentation of women – especially in leadership roles – we are proud to have trailblazers like Beth and Alex.” Benchmark’s extensive research process encompasses months of investigation into the individual litigators’ professional activities as well as client feedback surveys and individual …

Wilkinson Walsh Again Named “Boutique Firm of the Year” by Benchmark

WASHINGTON, D.C. — Benchmark Litigation again named Wilkinson Walsh the “Boutique Firm of the Year” during its annual awards ceremony in New York City — the second time in three years that Wilkinson Walsh has received the recognition. This prestigious award recognizes Wilkinson Walsh’s high-profile trial wins over the last year, including a defense verdict for the National Collegiate Athletic Association (NCAA) in McNair v. NCAA and multiple state-court bellwether trial victories for Bayer in trials involving the blood-thinner Xarelto. Wilkinson Walsh also achieved several other pre- and post-trial victories in 2018, including judgment granted as a matter of law to Wilkinson Walsh’s clients Oculus and Facebook on plaintiffs’ false designation claim in Zenimax Media et al. v. Oculus VR and complete dismissal, before any discovery, of a securities fraud class action case in In re MAXIMUS, Inc. Securities Litig. “We are deeply appreciative of Benchmark’s recognition of our firm for …

Litigation Daily: “Killer Crosses: How Wilkinson Walsh Partners Shredded Witnesses in $600M Save for Bayer”

After the Wilkinson Walsh team, led by Sean Eskovitz, Alex Walsh, James Rosenthal, and Kieran Gostin, won a decisive victory for Bayer in a $600 million certified consumer class action lawsuit brought on behalf of One A Day multivitamin consumers, Litigation Daily‘s Jenna Greene wrote about how Eskovitz and Walsh were “so good” at the cross-examinations that “the Wilkinson Walsh team called no defense witnesses. They annihilated the case on crosses alone”: If cross-examination is an art form, then Wilkinson Walsh name partners Alexandra Walsh and Sean Eskovitz (pictured above) are masters. The duo led a trial team defending Bayer AG, which faced a $600 million certified consumer class action over its One A Day multivitamin. The plaintiffs alleged Bayer made false and misleading claims that One A Day supported heart health, immunity and physical energy. How good were the cross-examinations? So good that that the Wilkinson Walsh team called no defense witnesses. They annihilated the case on …

Wilkinson Walsh Secures Trial Win for Bayer in $600 Million One A Day Class Action

WASHINGTON, D.C. — The Wilkinson Walsh team, led by Sean Eskovitz, Alex Walsh, James Rosenthal, and Kieran Gostin, won a decisive victory for Bayer in a $600 million certified consumer class action lawsuit brought on behalf of One A Day multivitamin consumers.  Without calling any witnesses in the defense case, the team relied on devastating cross-examinations of plaintiffs’ expert and fact witnesses to convince the jury to reject plaintiffs’ claims that Bayer had misrepresented the health benefits of One A Day multivitamins.  The jury deliberated for just an hour before returning a complete defense verdict.  The class action suit, filed on behalf of purchasers of One A Day multivitamins in California, New York, and Florida, challenged as false and misleading Bayer’s claims that One A Day multivitamins support heart health, immunity, and physical energy. Plaintiffs originally sought over $4 billion in damages, which Wilkinson Walsh successfully reduced to $600 million …